Literature DB >> 24609734

Clinical aspects of granulomatosis with polyangiitis affecting the head and neck.

Andreas Knopf1, Adam Chaker, Thomas Stark, Benedikt Hofauer, Tobias Lahmer, Klaus Thürmel, Murat Bas.   

Abstract

There are many controversies in head and neck granulomatosis with polyangiitis (HN-GPA). Diagnostic/therapeutic regimens vary due to limited knowledge about the special properties of HN-GPA. 28 patients were diagnosed with GPA accordingly. Anti-neutrophil-cytoplasmatic-antibody (ANCA), anti-peroxidase-antibody (anti-PR3) and biopsies were performed for all patients and set into clinical context. 14 patients had sinonasal symptoms. Otological (n = 8) and laryngeal (n = 2) symptoms were usually associated with complex disease activity. Pulmonary and/or renal impairment was present in 14 patients at the time of diagnosis and developed in a further nine patients within 1 year. 21 patients with systemic disease displayed elevated ANCA/anti-PR3. In contrast, those with persistent isolated HN manifestations (n = 6) lacked auto-antibodies. These patients underwent multiple biopsies to diagnose GPA. Interestingly, five patients without clinical HN manifestations but elevated auto-antibodies were identified by nasal "blind" biopsy. Clinical examination, auto-antibody testing, and histology are effective diagnostic tools in HN-GPA. Histological diagnosis remains the gold standard in patients with persistent isolated head and neck manifestations but missing auto-antibodies. Based on our findings, we suggest early and sufficient systemic therapy for all HN-GPA. Nasal mucosal "blind" biopsy should be performed in patients with elevated auto-antibodies but lacking clinical head and neck manifestations.

Entities:  

Mesh:

Year:  2014        PMID: 24609734     DOI: 10.1007/s00405-014-2973-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  33 in total

1.  Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.

Authors:  Gunnar Tomasson; Peter C Grayson; Alfred D Mahr; Michael Lavalley; Peter A Merkel
Journal:  Rheumatology (Oxford)       Date:  2011-10-29       Impact factor: 7.580

2.  [How can the diagnostic value of head and neck biopsies be increased in Wegener's granulomatosis: a clinicopathologic study of 49 biopsies in 21 patients].

Authors:  Pierre Raynaud; Renaud Garrel; Valérie Rigau; Flora Poizat; Patrice Vic; César Cartier; Sophie Rivière; Pierre Baldet; Valérie Costes
Journal:  Ann Pathol       Date:  2005-04       Impact factor: 0.407

3.  Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases.

Authors:  Steven B Cannady; Pete S Batra; Curry Koening; Robert R Lorenz; Martin J Citardi; Carol Langford; Gary S Hoffman
Journal:  Laryngoscope       Date:  2009-04       Impact factor: 3.325

Review 4.  Head and neck involvement in Wegener's granulomatosis (WG).

Authors:  T J McDonald; R A DeRemee
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

5.  Otolaryngological progression of granulomatosis with polyangiitis after systemic treatment with rituximab.

Authors:  Ian-James Malm; David J Mener; Jean Kim; Philip Seo; Young J Kim
Journal:  Otolaryngol Head Neck Surg       Date:  2013-10-23       Impact factor: 3.497

6.  Progression and management of Wegener's granulomatosis in the head and neck.

Authors:  Stanford C Taylor; Daniel R Clayburgh; James T Rosenbaum; Joshua S Schindler
Journal:  Laryngoscope       Date:  2012-06-05       Impact factor: 3.325

Review 7.  The relation between Staphylococcus aureus and Wegener's granulomatosis: current knowledge and future directions.

Authors:  E R Popa; J W Cohen Tervaert
Journal:  Intern Med       Date:  2003-09       Impact factor: 1.271

8.  Hearing loss in Wegener's granulomatosis.

Authors:  Sivasanker Bakthavachalam; Mark S Driver; Clarke Cox; Jeffrey H Spiegel; Kenneth M Grundfast; Peter A Merkel
Journal:  Otol Neurotol       Date:  2004-09       Impact factor: 2.311

9.  Natural killer/T-cell lymphoma, nasal type, masquerading as recalcitrant periodontitis in a patient with a diagnosis of Wegener's granulomatosis.

Authors:  Małgorzata Sokołowska-Wojdyło; Aleksandra Florek; Wioletta Barańska-Rybak; Monika Sikorska; Anna Starzyńska; Barbara Drogoszewska; Adam Włodarkiewicz
Journal:  Am J Med Sci       Date:  2013-02       Impact factor: 2.378

10.  Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.

Authors:  John H Stone
Journal:  Arthritis Rheum       Date:  2003-08
View more
  5 in total

1.  [Manifestations of autoimmune disorders in otorhinolaryngology : Classical symptoms and diagnostic approach].

Authors:  B Hofauer; A Chaker; K Thürmel; A Knopf
Journal:  HNO       Date:  2017-08       Impact factor: 1.284

2.  Orbital complications:diagnosis of different rhinological causes.

Authors:  Yumiko Matsuba; Ulrich Strassen; Benedikt Hofauer; Murat Bas; Andreas Knopf
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-17       Impact factor: 2.503

3.  [Manifestation of eosinophilic granulomatosis with polyangiitis in the head and neck area over time taking systemic disease activity into consideration].

Authors:  Henrik Andersen; Paul Götz; Jan Phillip Bremer; Martin Laudien
Journal:  Z Rheumatol       Date:  2018-12       Impact factor: 1.372

4.  Facial nerve paresis in the course of masked mastoiditis as a revelator of GPA.

Authors:  Joanna Marszał; Anna Bartochowska; Randy Yu; Małgorzata Wierzbicka
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-11-19       Impact factor: 3.236

Review 5.  Supraglottic Localization of IgG4-Related Disease-Rare and Challenging Equity.

Authors:  Magda Barańska; Joanna Makowska; Małgorzata Wągrowska-Danilewicz; Wioletta Pietruszewska
Journal:  J Pers Med       Date:  2022-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.